Vahid Salimi

TL;DR: A comprehensive review of recent findings related to the role of miRNAs in different respiratory viral infections is presented and possible therapeutic opportunities aiming to attenuate the burden of viral infections are discussed.

TL;DR: It is shown that opioid receptor signaling is required to control respiratory syncytial virus replication and thereby to control disease severity, and it is also shown that caution is required before using pharmaceutical opioids as anti-inflammatory or antiviral treatment of patients with viral respiratory infection.

TL;DR: In this article, the authors pointed out the essential influential factors related to the host, virus, and environment affecting the clinical outcome of COVID-19, which leads to different clinical outcomes.

TL;DR: The findings clearly indicate that the response of each individual to infection is influenced by genetic diversity mainly linked to the regulation of host immune responses, which affects the balance between control of viral replication and tissue damage during RSV infection.

TL;DR: The clinical and epidemiological features of the first cases of SARS-CoV-2 confirmed in Iran are described and future research should focus on finding the routes of transmission for this virus, including the possibility of transmission from foreign tourists.